Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Developmental Dynamics : an Official Publication of the American Association of Anatomists|May 19, 2009
Analysis of heart valve development in larval zebrafishRichard Tyler Martin, Thomas BartmanDeath Studies|December 29, 2022
Qualities of the dying experience of persons who access medical assistance in dying: A scoping reviewTyler Martin, Shannon Freeman, Nasreen Lalani, et al.Academic Medicine : Journal of the Association of American Medical Colleges|February 27, 2024
Conceptualizing Educational Comparability in Distributed Health Professions Education: A Scoping ReviewHelen C H Hsu, Tyler Martin, Pim W Teunissen, et al.Vaccine|January 11, 2015
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease and type 2 diabetes mellitusJulia M Janssen, William L Heyward, J Tyler Martin, et al.Journal of Community Health|March 4, 2022
Examining the Macrosystem Level of Influence on Community Health Worker Effectiveness in the State of Nebraska: A Qualitative ApproachAshley Mulcahy Toney, Tyler Martin, Sophi Sanchez, et al.Human Vaccines & Immunotherapeutics|January 8, 2024
Saponin TQL1055 adjuvant-containing vaccine confers protection upon Mycobacterium tuberculosis challenge in miceMushtaq Ahmed, Eric Farris, Rosemary V Swanson, et al.Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 17, 2024
The impact of implementation of rapid blood culture identification panels on antimicrobial optimization: a retrospective cohort studyTyler Martin, Eli Wilber, Shreena Advani, et al.Journal of Urban Health : Bulletin of the New York Academy of Medicine|May 20, 2021
Nurtured in Nature: a Pilot Randomized Controlled Trial to Increase Time in Greenspace among Urban-Dwelling Postpartum WomenEugenia C South, Kathleen Lee, Kehinde Oyekanmi, et al.Vaccine|June 19, 2012
Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adultsScott A Halperin, Shelly McNeil, Joanne M Langley, et al.Vaccine|June 4, 2013
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of ageWilliam L Heyward, Michael Kyle, Joseph Blumenau, et al.Pageof 2